Skip to Main Content

Paper Details

Safety of intravenous lacosamide in hospitalized children and neonates.
Epilepsia
0
2023
LCM, Seizures, bradycardia, cardiac arrest, children, critically, decreased appetite, delirium, diarrhea, gait disturbance, hypertension, lacosamide, low blood pressure, nystagmus, pancreatitis, patients, pediatric, rash, somnolence, tachyarrhythmia, tachycardia, vomiting
Acetamides, Anticonvulsants, Bradycardia, Child, Child, Hospitalized, Cohort Studies, Humans, Infant, Newborn, Lacosamide, Retrospective Studies, Sleepiness, Treatment Outcome
Author NameAffiliation
Susan L FongCincinnati Children's Hospital Medical Center
Susan L FongUniversity of Cincinnati College of Medicine
Levon UtidjianChildren's Hospital of Philadelphia and University of Pennsylvania
Moninder KaurUCB Pharma
Nicholas S AbendChildren's Hospital of Philadelphia and University of Pennsylvania
M WainwrightUniversity of Washington
Krista M GrandeCincinnati Children's Hospital Medical Center
Nadia FoskettUCB Pharma
Robert RoeblingUCB Pharma
R??jean M GuerrieroWashington University School of Medicine and St. Louis Children's Hospital
Badal Jain
Suchitra RaoChildren's Hospital Colorado
Michael StoltenbergUCB Pharma
Paulette WilliamsUCB Pharma
Nancy YuenUCB Pharma
Kimberley DickinsonApplied Clinical Research Center, Children's Hospital of Philadelphia
Jill McDonaldApplied Clinical Research Center, Children's Hospital of Philadelphia
Mitchell G MaltenfortApplied Clinical Research Center, Children's Hospital of Philadelphia
Christopher B ForrestChildren's Hospital of Philadelphia and University of Pennsylvania
Christopher B ForrestApplied Clinical Research Center, Children's Hospital of Philadelphia
  • 1 - 20

Datasets

Release 1.2